These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1993570)

  • 1. 1 alpha,25-(OH)2D3 use on psoriasis and ichthyosis.
    Okano M
    Int J Dermatol; 1991 Jan; 30(1):62-4. PubMed ID: 1993570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis.
    Okano M
    Dermatology; 2001; 202(2):116-8. PubMed ID: 11306831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report.
    el-Azhary RA; Peters MS; Pittelkow MR; Kao PC; Muller SA
    Mayo Clin Proc; 1993 Sep; 68(9):835-41. PubMed ID: 8396699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
    Chen TC; Holick MF
    Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3.
    Chen ML; Perez A; Sanan DK; Heinrich G; Chen TC; Holick MF
    J Invest Dermatol; 1996 Apr; 106(4):637-41. PubMed ID: 8617997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha,25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain.
    Morimoto S; Imanaka S; Koh E; Shiraishi T; Nabata T; Kitano S; Miyashita Y; Nishii Y; Ogihara T
    Biochem Int; 1989 Nov; 19(5):1143-9. PubMed ID: 2561444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis with calcipotriol and other vitamin D analogues.
    Kragballe K
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1001-8. PubMed ID: 1479078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study.
    Durakovic C; Malabanan A; Holick MF
    Br J Dermatol; 2001 Mar; 144(3):500-6. PubMed ID: 11260006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective.
    Holick MF; Chen ML; Kong XF; Sanan DK
    J Investig Dermatol Symp Proc; 1996 Apr; 1(1):1-9. PubMed ID: 9627684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction.
    Oyama N; Iwatsuki K; Satoh M; Akiba H; Kaneko F
    Br J Dermatol; 2000 Dec; 143(6):1140-8. PubMed ID: 11122013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis.
    van de Kerkhof PC; van Bokhoven M; Zultak M; Czarnetzki BM
    Br J Dermatol; 1989 May; 120(5):661-4. PubMed ID: 2667612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1,25-dihydroxyvitamin D3 on adenylate cyclase and protein kinase C in pig epidermis.
    Koizumi H; Yasui C; Ohkawara A
    Acta Derm Venereol; 1991; 71(1):6-10. PubMed ID: 1676219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
    Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
    Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical administration of Vitamin A acid for ichthyosiform dermatoses and psoriasis.
    Frost P; Weinstein GD
    JAMA; 1969 Mar; 207(10):1863-8. PubMed ID: 4885330
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis.
    Smith EL; Pincus SH; Donovan L; Holick MF
    J Am Acad Dermatol; 1988 Sep; 19(3):516-28. PubMed ID: 2459166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis occurring in lamellar ichthyosis: response to Epilyt.
    Baden HP; Byers HR; Goldaber M
    Cutis; 1989 Jan; 43(1):41-3. PubMed ID: 2464458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.